baber/WOPTO huggingface dataset:
Patent AU-2020200115-A1 (AU)
Title: Methods, materials and apparatus for cleaning and inspecting girth gear sets
Inventor: SHUMKA THOMAS
IPC: B08B3/04
Filed: 2020-01-08
Abstract: METHODS, MATERIALS AND APPARATUS FOR CLEANING AND INSPECTING GIRTH GEAR SETS 
ABSTRACT 
A one-step method of cleaning a girth gear set of a mill in preparation for inspection is provided, 
the method comprising: substantially emptying the mill; inching the gear; spraying a low, very low 
or non-Volatile Organic Compound (VOC) cleaning formulation at high pressure onto the gear, the 
cleaning formulation comprising a non-VOC aliphatic hydrocarbon solvent, an extreme pressure 
lubricant, a fretting wear lubricant, a non-ionic surfactant, and a mixture of non-VOC unsaturated 
fatty alcohols; and continuing to spray the low or very low VOC cleaning formulation on the gear 
for sufficient time for the formulation to clean the gear, thereby providing a so cleaned gear.
Patent AU-2020201976-A1 (AU)
Title: Two dimensional touch interaction screens with content-aware sensors
Inventor: WILENSKY GREGG
IPC: G06T11/00
Filed: 2020-03-19
Abstract: OF THE DISCLOSURE 
The present disclosure relates to systems, methods, and non-transitory computer 
readable media that utilize context-aware sensors and multi-dimensional gesture inputs across 
a digital image to generate enhanced digital images. In particular, the disclosed systems can 
provide a dynamic sensor over a digital image within a digital enhancement user interface (e.g., 
a user interface without visual elements for modifying parameter values). In response to 
selection of a sensor location, the disclosed systems can determine one or more digital image 
features at the sensor location. Based on these features, the disclosed systems can select and 
map parameters to movement directions. Moreover, the disclosed systems can identify a user 
input gesture comprising movements in one or more directions across the digital image. Based 
on the movements and the one or more features at the sensor location, the disclosed systems 
can modify parameter values and generate an enhanced digital image.
2/16 
Identify User Selection Of A First Location 202 
(Detect Features Of The Digital Image At The First Location) 
Detect User Input Gesture Comprising A Movement 204 
Determine A Modification Based On The User Input Gesture 
(And Features Of The Digital Image At The First Location) 2Q6 
Ax- Change Saturation Of Color At First Location 
AY 
Ay- Change Hue Of Color At First Location 
Ax 
Generate Enhanced Digital Image 208 
Fig. 2
Patent AU-2020202924-A1 (AU)
Title: Integrated consumer genomic services
Inventor: NELSON NICHOLAS A
IPC: G06Q30/06
Filed: 2020-05-01
Abstract: A method for processing genomic information in a genomics environment, the method comprising: after a first user completes a first user transaction using a browser in a graphical user interface, storing first user transaction data in a central repository, wherein the first user 5 transaction includes at least one from the following: view a vendor, view a vendor offering, and purchase a vendor offering; after a second user completes a second user transaction on a second user device, storing second user transaction data in the central repository, wherein the second user transaction includes at least one from the following: view a vendor, view a vendor offering, and purchase a vendor offering; comparing the stored first user transaction data to the second 0 user transaction data to provide a record of overlapping transaction history; pushing a recommendation notification to the second user device in a graphical user interface with a recommended transaction offering based on the record of overlapping transaction history.
Patent AU-2020218296-A1 (AU)
Title: A node, system and method for detecting local anomalies in an overhead power grid
Inventor: BURSTRÖM STEFAN
IPC: G01R21/133
Filed: 2020-02-07
Abstract: The present invention relates to a node (10) for detecting local anomalies in an overhead power grid (1) having at least one power line (3-5). The node comprising a processing unit (13) and a memory (14), wherein the node further comprises: an electric field sensor (12) configured to measure a first parameter related to an electric field around the at least one power line (3-5),and a magnetic field sensor (11) configured to measure at least second parameter related to a magnetic field around the at least one power line (3-5). The processing unit (13) is configured to: compare the measured first parameter and at least second parameter with historic data stored in the memory (14) to identify local anomalies, and forward data related to the identified local anomalies to a system controller (22) via a communication interface (15).
Patent AU-2020226900-A1 (AU)
Title: Adaptive retrieval of objects from remote storage
Inventor: ALON BARAK
IPC: G06F3/06
Filed: 2020-02-21
Abstract: Various embodiments of the present application set forth a computer-implemented method for accessing data comprising identifying a first set of read operations occurring during a first time period, where each read operation included in the set of read operations is associated with retrieving a different portion of at least one object from a storage system, determining a byte density associated with the set of read operations, where the byte density indicates a size of contiguous portions of the at least one object that were retrieved during the first time period, and determining, based on the byte density, a pre-buffering block size for a read operation during a second period, where the pre-buffering block size specifies a size of a portion of at least one object that is to be retrieved from the storage system.
Patent AU-2020257051-A1 (AU)
Title: Weld seam testing chain
Inventor: BARBONE RICCARDO
IPC: G01N29/04
Filed: 2020-10-20
Abstract: Weld seam testing chain for testing a weld seam by means of ultrasound on two 
plastic tubes welded together at the ends, comprising standard chain links, wherein 
the standard chain links are hooked together to form the weld seam testing chain, 
and the chain can be lengthened or shortened individually, a sensor receptacle for 
accommodating the ultrasonic sensor, and an adjusting unit for the fine adjustment of 
the weld seam testing chain length, wherein the standard chain links have a hook on 
one side and a hook receptacle on the opposite side, thereby enabling the individual 
chain links to be hooked together.  
Figure 1
KN 
Nb N N-
Patent AU-2020265209-A1 (AU)
Title: Hip arthroplasty trial systems and associated medical devices, methods, and kits
Inventor: MORRISEY STEPHEN PATRICK
IPC: A61F2/46
Filed: 2020-04-27
Abstract: Hip arthroplasty trial systems (1, 100, 300, 500, 700) and associated medical devices (10, 110, 310, 510, 710), methods (200, 900, 1000), and kits (1100) are described that can be utilized in situ to complete a femoral head trial. An example embodiment of a hip arthroplasty trial system (1) includes a medical device (10) and a femoral stem (20). The medical device (10) has a head member (12), a spacer (14), a shaft (16), and a locking member (18). The spacer (14) is disposed within the head member (12) and is moveable from a first position to a second position. The shaft (16) is disposed within the head member (12) and contacts the femoral stem (20). The shaft (16) is moveable from a first position to a second position. Movement of the shaft (16) from the first position to the second position moves the spacer (14) from its first position to its second position. The locking member (18) is disposed within the head member (12) and releasably attaches the shaft (16) to the head member (12).
Patent AU-2020270492-A1 (AU)
Title: Helmet mounted visor
Inventor: FRIEDER III LEONARD P
IPC: A42B3/22
Filed: 2020-11-18
Abstract: A visor system for a helmet includes a lens sized to extend across at least a portion of a user's 
face, a frame secured along a top portion of the lens and configured to receive and abut against a 
front surface of the helmet, a first fastener coupled to a first end of the frame by a first flexible 
attachment, and a second fastener coupled to a second end of the frame by a second flexible 
attachment. The visor system may further include a first anchor releasably securable to the first 
fastener, the first anchor being mountable onto a first portion of the helmet, and a second anchor 
releasably securable to the second fastener, the second anchor being mountable onto a second 
portion of the helmet.  
FIG. 1A
1/18 
20220 
206b 206a 
134b 
... ... 300a..  
136b....  
122. .. ..  
114..04.116.156a 
132..136a.134a 
102....130.  
FIG ... ... 1A.
Patent AU-2020271352-A1 (AU)
Title: Combinations of anti-ILDR2 antibodies and PD-1 antagonists
Inventor: RÖSE LARS
IPC: A61P37/06
Filed: 2020-04-06
Abstract: The present invention relates to an anti-ILDR2 antibody, a fragment or derivative thereof, a modified antibody format, or an antibody mimetic for use in combination with a PD-1 antagonist in the treatment of cancer. Other aspects of the present invention relate to a combination comprising an anti-ILDR2 antibody and a PD-1 antagonist and the use of such combination as a medicament, as well as methods of treatment or prophylaxis of a cancer in a subject, comprising administering to said subject a therapeutically effective amount of the antibodies as described herein. Further, the present invention relates to a kit comprising anti-ILDR2 antibodies and PD-1 antagonists and optionally one or more further pharmaceutical agents.
Patent AU-2020271633-A1 (AU)
Title: Comprehensive detection of single cell genetic structural variations
Inventor: KORBEL JAN
IPC: G16B20/20
Filed: 2020-04-09
Abstract: [1] The present invention provides a method for detecting structural variations (SV) within genomes of single cells or population of single cells by integrating a three-layered information of sequencing read depth, read strand orientation and haplotype phase. The method of the invention can detect deletions, duplications, polyploidies, translocations, inversions, and copy number neutral loss of heterozygosity (CNN-LOH), and more. The method of the invention can fully karyotype a genome comprehensively, and may be applied in research and clinical approaches. For example, the methods of the invention are useful for analysing cellular samples of patients for diagnosing or aiding a diagnosis, in reproductive medicine to detect embryonic abnormalities, or during therapeutic approaches based on cellular therapies to quality control genetically engineered cells, such as in adoptive T cell therapy and others. The method of the invention may further be applied in research to decipher the karyotypes of cellular models (cell lines), patient samples, or to further unravel genetic and mechanistic pathways leading to the generation of any SV within genomes.
Patent AU-2020283906-A1 (AU)
Title: Anti-ADAM8 antibodies and uses of the same
Inventor: SONENSHEIN GAIL
IPC: A61K38/17
Filed: 2020-05-29
Abstract: Provided herein are proteins that inhibit both the metalloprotease activity and disintegrin activity of human ADAM8, wherein the protein comprises an antigen-binding domain that: (i) binds specifically to human ADAM8; and (ii) binds to an epitope within human ADAM8 that includes at least one amino acid within the sequence of SEQ ID NO: 1, nucleic acids, vectors, compositions, and methods of use thereof (e.g., methods of treatment and methods of diagnosing).
Patent AU-2020288141-A1 (AU)
Title: Ostomy pouch with filter path and filter
Inventor: BOTTEN RONALD S
IPC: A61F5/441
Filed: 2020-05-29
Abstract: An ostomy appliance includes an outer wall having first and second opposed sides joined at an outer periphery, an inlet and a filter assembly, wherein the outer wall defines an interior volume comprising a collection area and a filter flow path in fluid communication with the collection area. The filter flow path fluidically connects the filter assembly to the collection area. The ostomy appliance further includes one or more flow elements between the first side and the second side, the one or more flow elements disposed between the collection area and the filter assembly. The one or more flow elements may be sized and arranged to permit gas venting from the collection area to the filter assembly and restrict liquid and/or solid flow from the collection area to the filter assembly.
Patent AU-2020309176-A1 (AU)
Title: Functional nucleic acid molecules upregulating the translation of a frataxin mRNA
Inventor: GUSTINCICH STEFANO
IPC: C40B50/04
Filed: 2020-07-10
Abstract: There are disclosed functional nucleic acid molecules comprising at least one target binding sequence comprising a sequence reverse complementary to a frataxin mRNA sequence; and a regulatory sequence comprising a SINE B2 element or a functionally active fragment of a SINE B2 element or an internal ribosome entry site (IRES) sequence or an IRES derived sequence.
Patent AU-2020309312-A1 (AU)
Title: Methods for diagnosing the effectiveness of anti-tumor treatment
Inventor: WÜRFEL WOLFGANG
IPC: C12Q1/6886
Filed: 2020-07-06
Abstract: The present invention relates to a method for predicting whether a subject having a tumor responds to a tumor therapy selected from (i) an immunotherapy, (ii) a chemotherapy, (iii) an anti-hormonal therapy, and (iv) an anti-tyrosin kinase therapy, wherein the method comprises (A) determining the level(s) of at least one nucleic acid molecule and/or at least one protein or peptide in a sample obtained from said subject, wherein the at least one nucleic acid molecule is selected from nucleic acid molecules (a) encoding a polypeptide comprising or consisting of the amino acid sequence of any one of SEQ ID NOs 1 to 6, (b) consisting of the nucleotide sequence of any one of SEQ ID NOs 7 to 12, (c) encoding a polypeptide which is at least 85% identical, preferably at least 90% identical, and most preferred at least 95% identical to the amino acid sequence of (a), (d) consisting of a nucleotide sequence which is at least 95% identical, preferably at least 96% identical, and most preferred at least 98% identical to the nucleotide sequence of (b), (e) consisting of a nucleotide sequence which is degenerate with respect to the nucleic acid molecule of (d), (f) consisting of a fragment of the nucleic acid molecule of any one of (a) to (e), said fragment comprising at least 150 nucleotides, preferably at least 300 nucleotides, more preferably at least 450 nucleotides, and most preferably at least 600 nucleotides, and (g) corresponding to the nucleic acid molecule of any one of (a) to (f), wherein T is replaced by U, and wherein the at least one protein or peptide is selected from proteins or peptides being encoded by the nucleic acid molecule of any one of (a) to (g); and (B) comparing the level(s) of (A) with the level(s) of the at least one nucleic acid molecule and/or the at least one protein or peptide in a sample obtained from one or more subjects that responded to one or more of the therapies of (i) to (iii) or a corresponding pre-determined standard, wherein increased level(s) of (A) as compared to the level(s) or pre-determined standard of (B) indicate(s) that the subject will not respond to the tumor therapy and substantially the same or decreased level(s) of (A) as compared to the level(s) of (B) indicate(s) that the subject will respond to the tumor therapy; or (B') comparing the level(s) of (A) with the level(s) of the at least one nucleic acid molecule and/or the at least one protein or peptide in a sample obtained from one or more subjects that did not respond to one or more of the therapies of (i) to (iii) or a corresponding pre-determined standard, wherein decreased level(s) of (A) as compared to the level(s) or pre-determined standard of (B') indicate(s) that the subject will respond to the tumor therapy and substantially the same or increased level(s) of (A) as compared to the level(s) of (B') indicate(s) that the subject will not respond to the tumor therapy.
Patent AU-2020310538-A1 (AU)
Title: Compounds comprising a fibroblast activation protein ligand and use thereof
Inventor: OSTERKAMP FRANK
IPC: G01N33/543
Filed: 2020-07-08
Abstract: The present invention is related to a compound comprising a cyclic peptide and a chelator, and its use.
Patent AU-2020319160-A1 (AU)
Title: Small molecule inhibitors of acetyl coenzyme A synthetase short chain 2 (ACSS2)
Inventor: BASU SOURAV
IPC: A61P31/04
Filed: 2020-07-24
Abstract: The present invention relates to compounds of formula (I). The compounds may be used to modulate the acetyl coenzyme A synthetase short chain
Patent AU-2020395752-A1 (AU)
Title: Device and method for nucleation of a supercooled beverage
Inventor: STOENESCU ELEONOR DORIN
IPC: B01D9/04
Filed: 2020-11-23
Abstract: A beverage nucleation device includes a housing, a beverage receiving area defined by the housing for receiving a beverage container containing a supercooled beverage, and a support configured to support the beverage container in an upright orientation in the beverage container receiving area. The beverage nucleation device may further include an applicator configured to contact a sidewall of the beverage container on the support, wherein the applicator includes an elastomeric material. An ultrasonic transducer of the beverage nucleation device is configured to generate and apply ultrasonic energy to the beverage container via the applicator so as to cause nucleation of the supercooled beverage.
Patent AU-2020403155-A1 (AU)
Title: Therapeutic cell compositions and methods for manufacture and uses thereof
Inventor: GETTS DANIEL
IPC: A61K38/00
Filed: 2020-12-11
Abstract: The present disclosure provides compositions and methods for making and using engineered killer phagocytic cells for immunotherapy in cancer or infection by expressing a chimeric antigen receptor having an enhanced phagocytic activity, the chimeric receptor is encoded by a recombinant nucleic acid.
Patent AU-2021201761-A1 (AU)
Title: Adhesive tape dispenser head
Inventor: VERRALL LUKE
IPC: B26D1/00
Filed: 2021-03-22
Abstract: 5 
We provide an adhesive tape dispenser head assembly arranged to dispense pieces of adhesive tape onto 
an object, the assembly comprising: a feed spool arranged to hold adhesive tape; a tape launching cutter 
movable between a first configuration in which the tape launching cutter is arranged to launch the adhesive 
tape onto the moving object and a second configuration in which the tape launching cutter is arranged to 
10 cut the tape to a desired length.  
A14734AU
1/5 
C0 
00 
-~ LL 
0 -4 
M C 
M 
00 
r-4 
T7071131A177 TQ/1T07T707
Patent AU-2021208113-A1 (AU)
Title: Azabicyclic substituted oxaspiro derivative, preparation method therefor and medical use thereof
Inventor: HU BIN
IPC: C07D487/04
Filed: 2021-01-15
Abstract: Provided are an azabicyclic substituted oxaspiro derivative, a preparation method therefor and a medical use thereof. Specifically, provided are compounds represented by formula (I) and formula (II) or pharmaceutically acceptable salts, stereoisomers or solvates thereof, and a preparation method therefor and an application thereof.
Patent AU-2021213358-A1 (AU)
Title: Method for operating at least one wind turbine and wind turbine or group of wind turbines
Inventor: MADSEN FINN DAUGAARD
IPC: H02J3/28
Filed: 2021-01-11
Abstract: Method for operating at least one wind turbine (1), the wind turbine (1) being electrically coupled to a power-to-gas converter (4) and an electric grid (3), wherein a control unit (5) determines a power level (20) for the power generated by at least one generator (2) of the at least one wind turbine (1) and at least partially feeds the generated power to the power-to-gas converter (4) when the determined power level (20) reaches or exceeds a given lower threshold value (15), wherein the amount of power fed to the power-to-gas converter (4) is kept constant when the determined power level (20) reaches or exceeds a given upper threshold value (17).
Patent AU-2021216189-A1 (AU)
Title: Device and method for separating tissue from an intestine
Inventor: DE WINTER THOMAS JOZEF S
IPC: A22B5/00
Filed: 2021-02-04
Abstract: The invention relates to a tissue separating device for separating an intestine from a cluster of organs harvested from an animal, in particular porcine, ovine or bovine, the intestine being connected to the remainder of the cluster through tissue. The tissue separating device comprises a guiding device having at least one guiding surface configured to contact the intestine, and a tissue severing device configured to provide a separation in the tissue close to the intestine. The guiding device further comprises a first guiding member and a second guiding member being movable with respect to each other to define a gap configured to accommodate said tissue. The gap has a variable gap width. The tissue severing device is configured to be operative in the gap, wherein the tissue separating device further comprises a resilient member configured to exert a force on at least one of the first guiding member and the second guiding member, the resilient member force driving the first guiding member and the second guiding member towards each other.
Patent AU-2021252645-A1 (AU)
Title: Electrocardiogram analysis
Inventor: ANASTASIA LUIGI
IPC: G16H40/63
Filed: 2021-04-07
Abstract: A computer-implemented method of facilitating electrocardiogram ("ECG") analysis involves receiving one or more sensed ECG traces for a patient, each of the sensed ECG traces representing sensed patient heart activity over a sensed time period, and, for each of the one or more sensed ECG traces: identifying a plurality of corresponding sensed ECG trace segments, each of the sensed ECG trace segments representing sensed patient heart activity for the patient over a segment of the sensed time period, and determining a representative ECG trace based on at least one of the identified corresponding sensed ECG trace segments. The method involves causing at least one neural network classifier to be applied to the one or more determined representative ECG traces to determine one or more diagnostically relevant scores related to at least one diagnosis of the patient. Other methods, systems, and computer readable media are disclosed.
Patent AU-2021257892-A1 (AU)
Title: Circulating RNA signatures specific to preeclampsia
Inventor: MUNCHEL SARAH E
IPC: C12Q1/6883
Filed: 2021-10-25
Abstract: CIRCULATING RNA SIGNATURES SPECIFIC TO PREECLAMPSIA 
The present invention includes methods and materials for use in the detection 
0 preeclampsia and/or determining an increased risk for preeclampsia in a pregnant female, the 
method including identifying in a biosample obtained from the pregnant women a plurality of 
circulating RNA (C-RNA) molecules.  
5 
100
Patent AU-2021265580-A1 (AU)
Title: CCR7 antibody drug conjugates for treating cancer
Inventor: ASKOXYLAKIS VASILEIOS
IPC: A61K47/68
Filed: 2021-04-28
Abstract: This application discloses compositions and methods of treating follicular lymphoma using CCR7 antibody drug conjugates. Also disclosed herein are methods of treating cancer in a subject in need thereof, comprising administering to said subject an antibody drug conjugate, wherein the cancer expresses CCR7, wherein the antibody drug conjugate is administered to said subject at about 0.1 mg/kg to about 10 mg/kg.